Table 4. Neonatal and maternal complications.
| Complications | EO-PE (n = 96) | LO-PE (n-289) | OR (95% CI) |
|---|---|---|---|
| n (%) | n (%) | ||
| Proportion of neonates with complications* | 96(39.8) | 56(16.4) | 2.4(1.6–3.5) |
| Neonatal complications | |||
| Respiratory distress syndrome (RDS)* | 56(58.3) | 22(7.6) | 16.9(9.0–32.2) |
| Neonatal jaundice† | 22(22.9) | 15(5.2) | 5.4(2.5–11.8) |
| Asphyxia | 9(9.4) | 15(5.2) | 1.9(0.7–4.8) |
| Neonatal convulsion | 3(3.1) | 4(1.4) | N/A |
| Necrotizing enterocolitis (NEC) | 6(6.3) | 0(0.0) | N/A |
| Maternal complications | (n = 232) | (n = 341) | |
| Antepartum Hemorrhage-† | 8 (3.3) | 2 (0.6) | 5.8(1.1–56.8) |
| HELLP* | 29 (13.0) | 10 (3.0) | 4.3(2.0–10.1) |
| Postpartum Hemorrhage | 9 (3.7) | 15 (4.4) | 0.8(0.3–2.1) |
| Renal Failure | 14 (5.8) | 12 (3.5) | 1.7(0.7–4.1) |
| Cerebral Vascular Accident /Stroke | 4 (1.7) | 3 (0.9) | N/A |
| Retinal Detachment/Blindness | 0 (0.0) | 0 (0.0) | N/A |
| Disseminated Intravascular Coagulation (DIC) | 0 (0.0) | 2 (0.6) | N/A |
| Pulmonary Oedema | 0 (0.0) | 1 (0.3) | N/A |
| Deep Vein Thrombosis | 0 (0.0) | 2 (0.6) | N/A |
| Dialysis required | 8 (3.0) | 6 (2.0) | 1.9(0.6–6.6) |
| Transfusion required | 24 (9.9) | 23 (6.7) | 1.5(0.8–2.9) |
| Death | 1 (0.4) | 5 (2.0) | N/A |
| Proportion of women with PE who experienced any complication* | 164(60.1) | 104(29.9) | 3.5(2.5–5.0) |
| Length of stay | |||
| Intensive Care Unit/ High Dependency Unit admission | 8 (3.0) | 10 (3.0) | 1.13(0.4–3.2) |
| Prolonged Hospital Stay > 1 week* | 155 (67.0) | 81 (24.0) | 5.7(3.9–8.4) |
* p <0.001
† p<0.01; N/A–not available due to fewer/no cases; OR—Odds Ratios; CI—Confidence Interval. Analysis excludes 37 women discharged at ANC